Amarin Corp PLC (AMRN)
0.8657
+0.01
(+0.74%)
USD |
NASDAQ |
Apr 22, 16:00
0.8631
0.00 (0.00%)
After-Hours: 20:00
Amarin Price to Book Value: 0.6293 for April 22, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| April 22, 2024 | 0.6293 |
| April 19, 2024 | 0.6247 |
| April 18, 2024 | 0.6338 |
| April 17, 2024 | 0.6667 |
| April 16, 2024 | 0.6513 |
| April 15, 2024 | 0.6678 |
| April 12, 2024 | 0.6957 |
| April 11, 2024 | 0.7415 |
| April 10, 2024 | 0.756 |
| April 09, 2024 | 0.7706 |
| April 08, 2024 | 0.7779 |
| April 05, 2024 | 0.7633 |
| April 04, 2024 | 0.7706 |
| April 03, 2024 | 0.7706 |
| April 02, 2024 | 0.7197 |
| April 01, 2024 | 0.6412 |
| March 28, 2024 | 0.6476 |
| March 27, 2024 | 0.6464 |
| March 26, 2024 | 0.6296 |
| March 25, 2024 | 0.6135 |
| March 22, 2024 | 0.625 |
| March 21, 2024 | 0.6263 |
| March 20, 2024 | 0.6521 |
| March 19, 2024 | 0.6306 |
| March 18, 2024 | 0.6085 |
| Date | Value |
|---|---|
| March 15, 2024 | 0.6244 |
| March 14, 2024 | 0.5975 |
| March 13, 2024 | 0.6274 |
| March 12, 2024 | 0.6285 |
| March 11, 2024 | 0.6512 |
| March 08, 2024 | 0.6711 |
| March 07, 2024 | 0.6739 |
| March 06, 2024 | 0.69 |
| March 05, 2024 | 0.6841 |
| March 04, 2024 | 0.6717 |
| March 01, 2024 | 0.7706 |
| February 29, 2024 | 0.7779 |
| February 28, 2024 | 0.9596 |
| February 27, 2024 | 0.9814 |
| February 26, 2024 | 0.8796 |
| February 23, 2024 | 0.8651 |
| February 22, 2024 | 0.8777 |
| February 21, 2024 | 0.8666 |
| February 20, 2024 | 0.8852 |
| February 16, 2024 | 0.896 |
| February 15, 2024 | 0.9034 |
| February 14, 2024 | 0.8738 |
| February 13, 2024 | 0.8368 |
| February 12, 2024 | 0.896 |
| February 09, 2024 | 0.9034 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
0.4872
Minimum
Nov 02 2023
60.31
Maximum
Jul 05 2019
7.135
Average
2.585
Median
Aug 02 2021
Price to Book Value Benchmarks
| Trinity Biotech PLC | -- |
| DBV Technologies SA | 0.9069 |
| Adaptimmune Therapeutics PLC | 6.309 |
| Akari Therapeutics PLC | -- |
| Biodexa Pharmaceuticals Plc | 0.5629 |
Price to Book Value Related Metrics
| PS Ratio | 1.150 |
| Price to Free Cash Flow | 55.60 |
| Price | 0.8657 |
| Earnings Yield | -17.33% |
| Market Cap | 347.45M |